Thymopentin

DRUG8 trials

Sponsors

Immunobiology Research Institute, Fudan University

Conditions

HIV InfectionsHepatocellular Carcinoma

Phase 2

A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs

CompletedNCT00002332

Immunobiology Research InstituteHIV Infections

Target: 60Updated: 2005-06-24

Phase 3

Double-Blind Study of Timunox (Thymopentin) in Asymptomatic HIV-Infected Patients Receiving Either Mono (AZT or ddI) or Combination (AZT / ddI or AZT / ddC) Anti-Retroviral Therapy

CompletedNCT00002109

Immunobiology Research InstituteHIV Infections

Updated: 2005-06-24

Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma

Fudan UniversityHepatocellular Carcinoma

Start: 2007-02-28End: 2012-02-29Target: 220Updated: 2007-10-31

Unknown Phase

A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients

CompletedNCT00002050

Immunobiology Research InstituteHIV Infections

Updated: 2005-06-24

The Effects of Thymopentin on HIV Infectivity of Blood Cells and Semen in HIV-Infected Patients

CompletedNCT00002289

Immunobiology Research InstituteHIV Infections

Updated: 2005-06-24

Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection

CompletedNCT00002066

Immunobiology Research InstituteHIV Infections

Updated: 2005-06-24

Double Blind Study of Thymopentin Effects on Patients With HIV-1 Infection

CompletedNCT00002051

Immunobiology Research InstituteHIV Infections

Updated: 2005-06-24

Double Blind Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients

CompletedNCT00002049

Immunobiology Research InstituteHIV Infections

Updated: 2005-06-24